Israel
· Delayed Price · Currency is ILS · Price in ILA Nextage Therapeutics Statistics
Total Valuation
TLV:NXTG has a market cap or net worth of ILS 23.32 million. The enterprise value is 23.51 million.
| Market Cap | 23.32M |
| Enterprise Value | 23.51M |
Important Dates
The last earnings date was Thursday, June 12, 2025.
| Earnings Date | Jun 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLV:NXTG has 33.70 million shares outstanding. The number of shares has increased by 187.70% in one year.
| Current Share Class | 33.70M |
| Shares Outstanding | 33.70M |
| Shares Change (YoY) | +187.70% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 58.43% |
| Owned by Institutions (%) | n/a |
| Float | 5.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 56.46 |
| PB Ratio | -4.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.16 |
| EV / Sales | 56.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -127.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -296.88% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 62.53% |
| Revenue Per Employee | 13,323 |
| Profits Per Employee | -105,903 |
| Employee Count | 31 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.29% in the last 52 weeks. The beta is 0.22, so TLV:NXTG's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -11.29% |
| 50-Day Moving Average | 95.14 |
| 200-Day Moving Average | 84.47 |
| Relative Strength Index (RSI) | 26.93 |
| Average Volume (20 Days) | 43,542 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:NXTG had revenue of ILS 413,000 and -3.28 million in losses. Loss per share was -0.10.
| Revenue | 413,000 |
| Gross Profit | 76,000 |
| Operating Income | -3.44M |
| Pretax Income | -3.47M |
| Net Income | -3.28M |
| EBITDA | -3.41M |
| EBIT | -3.44M |
| Loss Per Share | -0.10 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 210,000 |
| Net Cash | -210,000 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -5.54M |
| Book Value Per Share | -0.16 |
| Working Capital | -5.54M |
Cash Flow
| Operating Cash Flow | -795,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 18.40% |
| Operating Margin | -832.69% |
| Pretax Margin | -840.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLV:NXTG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -187.70% |
| Shareholder Yield | n/a |
| Earnings Yield | -14.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |